Spots Global Cancer Trial Database for lenalidomide po (25mg)
Every month we try and update this database with for lenalidomide po (25mg) cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Compare Lenalidomide and Subcutaneous Daratumumab vs Lenalidomide and Dexamethasone in Frail Subjects With Previously Untreated Multiple Myeloma Who Are Ineligible for High Dose Therapy | NCT03993912 | Multiple Myelom... | Daratumumab SC ... Lenalidomide PO... Dexamethasone P... | 65 Years - | University Hospital, Lille |